We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Chemicon and Axordia to Co-Develop Antibody Markers

News   Oct 03, 2005

 
Chemicon and Axordia to Co-Develop Antibody Markers
 
 
 

RELATED ARTICLES

A Novel Therapeutic Target for Retinal Vein Occlusion

News

Researchers utilize a newly developed model of central retinal vein occlusion (CRVO) in mice to demonstrate the retinoprotective effects of the peptide adrenomedullin (ADM) and its receptor activity-modifying protein RAMP2.

READ MORE

Liver Hormone Puts the Brakes on Metabolism

News

Researchers have identified a hormone produced by the liver that tells the body to downshift its metabolism when it’s expending a lot of energy.

READ MORE

Blood-brain Barrier Breakdown Early Marker of Human Cognitive Dysfunction

News

Individuals with early cognitive function develop brain capillary damage and blood-brain barrier breakdown in the hippocampus, regardless of amyloid beta/tau biomarker changes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE